Search - tctmd.com

Displaying 421 - 440 of 649

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Opinion CV Team Dispatch

October 2020 News Roundup

L.A. McKeown

October 01, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

GARFIELD-AF: Wrong DOAC Dose Can Be Lethal in A-fib

Todd Neale

September 16, 2020

News Conference News

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

L.A. McKeown

September 10, 2020

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Conference News ESC 2020

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Michael O'Riordan

September 01, 2020

News Conference News ESC 2020

Dapagliflozin Wins in Patients With CKD

Todd Neale

August 31, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Shelley Wood

August 31, 2020

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Yael L. Maxwell

August 06, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Azithromycin Again Linked to Higher CV Mortality Risk

Caitlin E. Cox

June 23, 2020

News Daily News

Case by Case, a Portrait Emerges of COVID-19’s Cardiovascular Fingerprint

Caitlin E. Cox

June 15, 2020

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

L.A. McKeown

June 08, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for September 2020

October 2020 News Roundup

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

GARFIELD-AF: Wrong DOAC Dose Can Be Lethal in A-fib

Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA

Dapagliflozin Wins in Patients With CKD

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC

Could Statins Curb Fatal or Severe COVID-19? Some Clues

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Azithromycin Again Linked to Higher CV Mortality Risk

Case by Case, a Portrait Emerges of COVID-19’s Cardiovascular Fingerprint

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content